Nurix Therapeutics, Inc.
CBL INHIBITORS AND COMPOSITIONS FOR EXPANSION OF IMMUNE CELLS
Last updated:
Abstract:
Methods and compositions using novel Cbl inhibitors enhancing expansion of immune cells to increase the efficacy of cell-based immunotherapeutics are disclosed. Also provided are cell-based immunotherapy methods and compositions.
Status:
Application
Type:
Utility
Filling date:
23 Sep 2020
Issue date:
25 Mar 2021